Sugi Predict

Sugi Predict / Compounds / SCHEMBL856096

SCHEMBL856096

SCHEMBL856096

CC(CN)NC(=O)OCc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 1/20 0.58
▸ CTSK P43235 7/20 0.56
▸ CA12 O43570 1/20 0.55
▸ CA1 P00915 1/20 0.55
▸ CA2 P00918 1/20 0.55
▸ CA9 Q16790 1/20 0.55
▸ CTRB1 P17538 2/20 0.55
▸ ELANE P08246 2/20 0.54
▸ CTSS P25774 6/20 0.53
▸ CTSL P07711 5/20 0.53
▸ CTSB P07858 3/20 0.52
▸ PRTN3 P24158 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4426192 1.00 ATM (0.58) ATMCTSKCA12CA1CA2
SCHEMBL2627372 1.00 ATM (0.58) ATMCTSKCA12CA1CA2
Hydrochloric Acid SCHEMBL3557214 0.98 ATM (0.57) ATMCTSKCA12CA1CA2
Hydrochloric Acid SCHEMBL3557210 0.98 ATM (0.57) ATMCTSKCA12CA1CA2
Hydrochloric Acid SCHEMBL3558669 0.98 ATM (0.57) ATMCTSKCA12CA1CA2
SCHEMBL18381502 0.88 ATM (0.59) ATMCTSKCA12CA1CA2
Hydrochloric Acid SCHEMBL5241109 0.87 ATM (0.58) ATMCTSKCA12CA1CA2
SCHEMBL13572927 0.86 ATM (0.59) ATMCTSKCTRB1ELANECTSS
SCHEMBL5268187 0.86 ATM (0.59) ATMCTSKCA12CA1CA2
SCHEMBL6407665 0.86 ATM (0.59) ATMCTSKCTRB1ELANECTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025016294-A1 RNAI AGENT FOR INHIBITING EXPRESSION OF KETOHEXOKINASE AND USE THEREOF 云合智药（苏州）生物科技有限公司 2025-01-23 — — WO disclosed
CN-118804921-A Conjugate, ligand unit and use thereof 云合智药（苏州）生物科技有限公司 2024-10-18 — — CN disclosed
WO-2024152775-A1 CONJUGATE, LIGAND UNIT AND USE THEREOF 云合智药（苏州）生物科技有限公司 2024-07-25 — — WO disclosed
US-11834391-B2 Pantothenamide analogues MMV MEDICINES FOR MALARIA VENTURE (CH) 2023-12-05 — — US disclosed
CN-113286778-B Ubiquitin analogs MMV疟疾药物投资公司 2023-09-22 — — CN disclosed
EP-3906225-B1 PANTOTHENAMIDE ANALOGUES MEDICINES FOR MALARIA VENTURE MMV (CH) 2023-07-05 — — EP disclosed
US-20230159437-A1 PANTOTHENAMIDE ANALOGUES MMV MEDICINES FOR MALARIA VENTURE (CH) 2023-05-25 — — US disclosed
CN-113286778-A Panamide analogs MMV疟疾药物投资公司 2021-08-20 — — CN disclosed
US-20140107100-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture EXELIXIS, INC. (US) 2014-04-17 — — US disclosed
US-20140080810-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture EXELIXIS, INC. (US) 2014-03-20 — — US disclosed
US-20070189969-A1 Perfluoroalkyl-containing complexes, process for their production as well as their use BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-08-16 — — US disclosed
WO-2007009638-A2 COMPLEXES CONTAINING PERFLUOROALKYL, METHOD FOR THE PRODUCTION AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-01-25 — — WO disclosed
US-20050250765-A1 Diazepinones as antiviral agents CHO HIDETSURA 2005-11-10 — — US disclosed
US-20040116410-A1 Diazepinones as antiviral agents CHO HIDETSURA (JP) 2004-06-17 — — US disclosed
US-4560755-A VASODILATOR, HYPOTENSOR ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1985-12-24 — — US disclosed
US-4525589-A Isoquinolinesulfonyl derivatives ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1985-06-25 — — US disclosed
EP-0061673-B1 ISOQUINOLINESULFONYL DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1984-10-24 — — EP disclosed
US-4456757-A MUSCLE RELAXANTS, VASODILATORS, HYPOTENSIVE AGENTS ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1984-06-26 — — US disclosed
EP-0109023-A1 Isoquinolinesulfonamide derivatives and process for the preparation thereof Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1984-05-23 — — EP disclosed
EP-0061673-A1 Isoquinolinesulfonyl derivatives and process for the preparation thereof Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1982-10-06 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070189969-A1 Perfluoroalkyl-containing complexes, process for their production as well as their use AFF1, FGB, PF4 ATM 1104/4885CTSK 3666/4885CA12 2830/4885
US-20050250765-A1 Diazepinones as antiviral agents ZC3HAV1, ECI1, ZC3HAV1L ATM 4785/4885CTSK 2200/4885CA12 2276/4885
US-20140107100-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture MTOR, RICTOR, PIK3CA ATM 2477/4885CTSK 2148/4885CA12 2980/4885
US-20140080810-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture MTOR, RICTOR, PIK3CA ATM 2042/4885CTSK 2146/4885CA12 3538/4885
US-11834391-B2 Pantothenamide analogues NAMPT, VKORC1, NME4 ATM 4720/4885CTSK 2108/4885CA12 4644/4885
US-20230159437-A1 PANTOTHENAMIDE ANALOGUES NAMPT, VKORC1, NME4 ATM 4720/4885CTSK 2108/4885CA12 4644/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.